The Sex‐Stratified Effects of RSPO3 Expression on Body Fat and Blood Lipids: An Omics Mendelian Randomization Study
Obesity · 2026-08 · 34 (8) · 1623-1634
DOI: 10.1002/oby.70252 ↗Kurz gefasst
Fachartikel in der Zeitschrift Obesity, online erschienen am 08.07.2026. Verfasst von Yihua Guo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong Universit…. Hauptthemen laut MEDLINE: Thrombospondins, Adipose Tissue, Lipids. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Key Research and Development Program of China, Noncommunicable Chronic Diseases-National Science and Technology Major Project, Lingang laboratory.
Abstract (Originalsprache)
Objective
This study examined sex‐stratified effects of R‐spondin 3 (RSPO3) expression levels on body fat and blood lipids and their potential mediation effects through sex hormones.
Methods
We performed a sex‐stratified genome‐wide association study (GWAS) of RSPO3 protein ( N = 18,529 men and 21,323 women). We used two‐sample Mendelian randomization (MR) to examine associations of RSPO3 expression with the outcomes. Sex‐stratified MR estimates were compared using the pairwise z score test and Cochran's Q test. We conducted two‐step MR analyses to explore mediation effects through sex hormones.
Results
Sex‐stratified GWAS identified nine loci associated with RSPO3 protein levels, including three novel signals and four female‐stratified loci. In women, RSPO3 protein levels were associated with visceral adipose tissue (β = 0.22, 95% CI = 0.10 to 0.34), waist circumference (0.10, 0.05 to 0.15), hip circumference (0.10, 0.05 to 0.15), triglycerides (0.22, 0.18 to 0.26), high‐density lipoprotein cholesterol (−0.17, −0.21 to −0.13), and apolipoprotein A (−0.11, −0.15 to −0.06). We also observed sex differences in these associations. Two‐step MR showed that RSPO3 protein levels affected six outcomes via sex hormone‐binding globulin in women, with little evidence in men.
Conclusions
Our findings indicated that RSPO3 could be a drug target for regulating body fat distribution and blood lipids in women.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- National Clinical Research Center for Endocrine and Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission, Shanghai Key Laboratory for Endocrine Tumor, Shanghai Digita…
- MRC Integrative Epidemiology Unit at University of Bristol, Bristol, UK.
ORCID-Profile: Jiqiu Wang
Förderung
- National Key Research and Development Program of China
- Noncommunicable Chronic Diseases-National Science and Technology Major Project
- Lingang laboratory
- National Natural Science Foundation of China
Zitieren
APA
Guo, Y., Chen, Z., Huang, L., Zhang, Z., Gong, Y., Yang, Q., Wang, J., & Zheng, J. (2026). The Sex‐Stratified Effects of RSPO3 Expression on Body Fat and Blood Lipids: An Omics Mendelian Randomization Study. Obesity, 34(8), 1623-1634. https://doi.org/10.1002/oby.70252
Vancouver
Guo Y, Chen Z, Huang L, Zhang Z, Gong Y, Yang Q, et al. The Sex‐Stratified Effects of RSPO3 Expression on Body Fat and Blood Lipids: An Omics Mendelian Randomization Study. Obesity. 2026;34(8):1623-1634. doi:10.1002/oby.70252
BibTeX
@article{Guo2026,
author = {Guo, Yihua and Chen, Zhihe and Huang, Lanhui and Zhang, Zhongyun and Gong, Yujia and Yang, Qian and Wang, Jiqiu and Zheng, Jie},
title = {The Sex‐Stratified Effects of RSPO3 Expression on Body Fat and Blood Lipids: An Omics Mendelian Randomization Study},
journal = {Obesity},
year = {2026},
volume = {34},
number = {8},
pages = {1623--1634},
doi = {10.1002/oby.70252}
}
EUVIMED